FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT | Reuters
U.S. health regulators are expected to authorize a booster shot of Pfizer /BioNTech's COVID-19 vaccine for children aged 5 to 11 as soon as Tuesday, the New York Times reported on Monday, citing people familiar with the matter.